एपीए उद्धरण

Sharon, Y., & Chu, D. S. (2020). Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis. Am J Ophthalmol Case Rep.

शिकागो स्टाइल उद्धरण

Sharon, Yael, और David S. Chu. "Certolizumab Pegol – Tumor Necrosis Factor Inhibitor for Refractory Uveitis." Am J Ophthalmol Case Rep 2020.

एमएलए उद्धरण

Sharon, Yael, और David S. Chu. "Certolizumab Pegol – Tumor Necrosis Factor Inhibitor for Refractory Uveitis." Am J Ophthalmol Case Rep 2020.